Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Methodist Transplant Physicians
mi
from
Dallas, TX
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Methodist Transplant Physicians
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Keck Medical Center of USC
mi
from
Los Angeles, CA
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Keck Medical Center of USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Ruth Rothstein Core Center
mi
from
Chicago, IL
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Ruth Rothstein Core Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated:  12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc.
mi
from
Richmond, VA
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
A Phase 3 Evaluation of Daclatasvir and Sofosbuvir With Ribavirin in Cirrhotic Subjects With Genotype 3 Chronic Hepatitis C Infection
Status: Enrolling
Updated: 12/31/1969
Bon Secours St. Mary's Hospital of Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
Status: Enrolling
Updated:  12/31/1969
Sandra Boimbo
mi
from
Aurora, CO
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
Status: Enrolling
Updated: 12/31/1969
Sandra Boimbo
mi
from
Aurora, CO
Click here to add this to my saved trials
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated:  12/31/1969
Cornell Medical Center
mi
from
New York, NY
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated: 12/31/1969
Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
University of California Davis Medical Center - Ticon 1
mi
from
Sacramento, CA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
University of California Davis Medical Center - Ticon 1
mi
from
Sacramento, CA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
University of Florida Hepatology Research at CTRB
mi
from
Gainesville, FL
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
University of Florida Hepatology Research at CTRB
mi
from
Gainesville, FL
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Advanced Liver Therapies, Baylor College of Medicine
mi
from
Houston, TX
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Advanced Liver Therapies, Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center - Organ Transplant and Liver Center
mi
from
Seattle, WA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center - Organ Transplant and Liver Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Ruane Clinical Research Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
California Pacific Medical Center
mi
from
San Francisco, CA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Tulane University
mi
from
New Orleans, LA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Methodist Dallas Medical Center
mi
from
Dallas, TX
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Texas Liver Institute
mi
from
San Antonio, TX
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Taxes Liver Institute
mi
from
San Antonio, TX
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Taxes Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Liver Test Study of Using JKB-122 in AIH Patients
A Phase 2, Pilot Study of JKB-122 to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington,
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
SCTI Research Foundation
mi
from
Coronado, CA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
SCTI Research Foundation
mi
from
Coronado, CA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Medical Center
mi
from
San Francisco, CA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Orlando Immunology Center
mi
from
Orlando, FL
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Medical Procare, Pllc
mi
from
Flushing, NY
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Medical Procare, Pllc
mi
from
Flushing, NY
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Office Of Sing Chan Md
mi
from
Flushing, NY
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Office Of Sing Chan Md
mi
from
Flushing, NY
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Beth Israel Med Ctr
mi
from
New York, NY
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Va New York Harbor Healthcare System
mi
from
New York, NY
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Va New York Harbor Healthcare System
mi
from
New York, NY
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson Medical College
mi
from
Philadelphia, PA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson Medical College
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
UPMC Center For Liver Diseases
mi
from
Pittsburgh, PA
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
UPMC Center For Liver Diseases
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Ciudad De Buenos Aires,
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated With Nucleoside/Nucleotide Monotherapy for Patients With Chronic HBV Infection: The REALM Study
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Ciudad De Buenos Aires,
Click here to add this to my saved trials